22
GENOMICS The science of studying whole genomes.

Genomics

Embed Size (px)

Citation preview

Page 1: Genomics

GENOMICS

The science of studying

whole genomes.

Page 2: Genomics

Genomics

• (1980s) the nucleotide sequences of many important genes from human and other organisms had been determined.

• (1990s) a team of scientists determined the nucleotide sequence of the entire genome of Haemophilus influenzae.

• The first targets of genomics research were pathogenic bacteria.

Page 3: Genomics

The Human Genome Project

• (1990) an international consortium of government-funded researchers began the Human Genome Project.

• (April 14, 2003) the Human Genome Project was successfully completed more than 2 years head of schedule.

Page 4: Genomics

The Human Genome Project

• The 24 different kinds of chromosomes in the human genome (22 autosomes plus the X and Y chromosomes) contain approximately 3.2 billion nucleotide pairs of DNA and 30,000 to 40,000 genes.

• Most complex eukaryotes have huge amount of noncoding DNA – about 97% of human DNA is made up of gene control type.

Page 5: Genomics

The Human Genome Project

• The remaining DNA has been called “junk DNA”, a tongue-in-cheek way of saying that scientists don’t understand its functions.

• Much of the DNA between genes consists of repetitive DNA.

Page 6: Genomics

The Human Genome Project

Repetitive DNANucleotide sequences present in many copies in the genome.

Main Types:1. A unit of just a few nucleotide pairs is repeated

many times in a row.2. Each repeated unit is hundreds of nucleotides

long and the copies are scattered around the genome.

Page 7: Genomics

Tracking the Anthrax Killer

• (October 2001) Bob Stevens, a 63-year-old editor at a Florida media company, died from inhalation anthrax, a disease caused by breathing spores of the bacterium Bacillus anthracis.

• Examining the genomes of the spores could answer several crucial questions.

• Investigators compared the genomes – which were 3 million nucleotides long – of the mailed anthrax spores with several laboratory strains.

Page 8: Genomics

Tracking the Anthrax Killer

• They were able to match the deadly spores with a laboratory subtype called the Ames strain.

• The Ames strain was first isolated from a dead Texas cow in 1981.

• The samples were sent to U.S. Army Medical Research Institute in Fort Detrick, Maryland.

• From there, it was sent to at least 14 other labs for use in experiments.

Page 9: Genomics

Tracking the Anthrax Killer

• Unfortunately, the date were not detailed enough to tie the mailed samples to any particular laboratory.

• The anthrax investigation is a prominent example of the new field of comparative genomics, the comparison of whole genomes.

Page 10: Genomics

Genome-Mapping Techniques

Genetic (Linkage) Mapping• Scientists combined pedigree analysis of large

families with DNA technology to map over 5,000 genetic markers.

• These markers included both coding regions (genes) and noncoding regions (such as strands of repetitive DNA).

• The low-resolution genetic map provided anchor points that enabled researchers to map other markers by testing for genetic linkage to the known markers.

Page 11: Genomics

Genome-Mapping Techniques

Physical Mapping• Researchers used several different restriction

enzymes to break the DNA of each chromosome into a number of identifiable fragments, which they cloned.

• They then determined the original order of the fragments in the chromosome by overlapping the fragments and matching up their ends.

• They used probes to relate the fragments to the markers mapped in stage 1.

• The end result was a series of DNA segments that spanned the genome in a known order.

Page 12: Genomics

Genome-Mapping Techniques

DNA Sequencing

• As the sequence of each cloned fragment from the physical map of stage 2 was determined, the fragments were reassembled in their proper order, producing large-scale sequences.

Page 13: Genomics

Genome-Mapping Techniques

The Whole Genome Shotgun Method• The procedure essentially skips the first two

stages described and proceeds directly to the third.

• An entire genome is chopped by restriction enzymes into fragments that are cloned and sequenced.

• High-performance computers running specialized mapping software can reassemble the millions of partial sequences into a entire genome.

Page 14: Genomics
Page 15: Genomics

HUMAN GENE THERAPY

A recombinant DNA procedure that seeks to treat disease by altering an

afflicted person’s genes.

Page 16: Genomics

Human Gene Therapy

1. A gene from a normal individual is isolated and cloned by recombinant DNA techniques.

2. The gene is inserted into a vector, such as a nonharmful virus.

3. The virus is then injectedto the patient.

Page 17: Genomics

Treating Severe Combined Immunodeficiency

Severe Combined Immunodeficiency (SCID)

A fatal inherited disease caused by a single defective gene.

Page 18: Genomics

Treating Severe Combined Immunodeficiency

• The first trial of began at the National Institutes of Health in 1990 on a 4-year-old girl with SCID.

• Immune system cells were periodically removed from her blood, infected with a virus engineered to carry the normal allele of the defective gene, then reinjected into her bloodstream.

• Her gene therapy lasted a limited time and was only one of the several treatments she received.

Page 19: Genomics

SAFETYAND

ETHICAL ISSUES

Page 20: Genomics

The Controversy OverGenetically Modified Foods

• Advocates of a cautious approach fear that crops from other species might be hazardous to human health or harm the environment.

Page 21: Genomics

Ethical Questions Raised byDNA Technology

• DNA technology raises many questions – moral, legal, and ethical – few of which have clear answers.

• Advances in genetic fingerprinting raise private issues.

• There is a danger that information about disease-associated genes could be abused.

Page 22: Genomics

Ethical Questions Raised byDNA Technology

• Should we try to eliminate genetic defects in our children and their descendants?

• Should we interfere with evolution this way?• Are we willing to risk making genetic changes

that could be detrimental to our species in the future?

• How do we really feel about wielding one of nature’s singular powers – the ability to make new microorganisms, plants, and even animals?